Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis
Non-coding RNA profiling · human · 36 samples
- What it is
- Non-coding RNA profilingLevels of RNAs that do not code for proteins, such as miRNA or lncRNA.
- Organism
- Homo sapiens (human)
- Topic
- Kidney cancerThis series is part of our curated briefing on it.
- Samples
- 36 samples: 36 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasisFrontiers in oncology · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE252630_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
Also filed as BioProject PRJNA1061531 and SRA study SRP482110. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 36 sample titles: 36 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8003764 human sample 1, stage 2
- GSM8003765 human sample 2, stage 1
- GSM8003766 human sample 3, stage 3
- GSM8003767 human sample 4, stage 1
- GSM8003768 human sample 5, stage 1
- GSM8003769 human sample 8, stage 3
- GSM8003770 human sample 9, stage 4
- GSM8003771 human sample 10, stage 2
- GSM8003772 human sample 12, stage 4
- GSM8003773 human sample 1s
- GSM8003774 human sample 2s
- GSM8003775 human sample 3s
- GSM8003776 human sample 4s
- GSM8003777 human sample 5s
- GSM8003778 human sample 8s
- GSM8003779 human sample 9s
- GSM8003780 human sample 10s
- GSM8003781 human sample 12s
- GSM8004179 human sample 1, stage 2 [miRNA]
- GSM8004180 human sample 2, stage 1 [miRNA]
- GSM8004181 human sample 3, stage 3 [miRNA]
- GSM8004182 human sample 4, stage 1 [miRNA]
- GSM8004183 human sample 5, stage 1 [miRNA]
- GSM8004184 human sample 8, stage 3 [miRNA]
- GSM8004185 human sample 9, stage 4 [miRNA]
- GSM8004186 human sample 10, stage 2 [miRNA]
- GSM8004187 human sample 12, stage 4 [miRNA]
- GSM8004188 human sample 1s [miRNA]
- GSM8004189 human sample 2s [miRNA]
- GSM8004190 human sample 3s [miRNA]
- GSM8004191 human sample 4s [miRNA]
- GSM8004192 human sample 5s [miRNA]
- GSM8004193 human sample 8s [miRNA]
- GSM8004194 human sample 9s [miRNA]
- GSM8004195 human sample 10s [miRNA]
- GSM8004196 human sample 12s [miRNA]
- GSE216494 Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity in vitro 12 samples same disease briefing · shares clear, renal
- GSE15641 Gene signatures of progression and metastasis in renal cell cancer 92 samples same disease briefing · shares metastasis, renal
- GSE216495 Nonclinical in-vitro evaluation of the transcriptomic and metabolic effects of immune checkpoint inhibitors on sunitinib-resistant renal cell carcinoma 36 samples same disease briefing · shares renal
- GSE19982 Gene expression discriminates chromophobe renal cell carcinoma and oncocytoma 30 samples same disease briefing · shares renal
- GSE174740 Drug repurposing identifies a synergistic high-order drug combination to treat sunitinib-resistant renal cell carcinoma 11 samples same disease briefing · shares renal
- GSE193006 Transcriptome RNA sequencing data of sarcomatoid renal cell carcinoma cell line SRCC and its subclones with different phenotypes. 5 samples same disease briefing · shares renal
- GSE17895 Somatic Mutation Screen of Clear Cell RCC 160 samples same disease briefing · shares clear
- GSE22316 PBRM1 Knockdown in RCC Cell Lines 89 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.